Evotaz, Atripla HIV Drugs Antitrust Class Action Lawsuit

The settlement will benefits patients, purchasers, and all other entities who paid for brand-name or generic Atripla or Evotaz between May 14, 2015, and Oct. 13, 2021. You may be eligible for a potential award from the Evotaz, Atripla HIV Drugs Antitrust Class Action Lawsuit!

According to the class action, the bank failed to properly update credit reporting when selling accounts to other lenders. So if you are eligible, file a claim by June 27, 2022 to receive your potential award!

Table of Contents

Evotaz, Atripla HIV Drugs Antitrust CAL

Claim Form Deadline: June 27, 2022
Who’s Eligible: Settlement benefits patients, purchasers, and all other entities who paid for brand-name or generic Atripla or Evotaz between May 14, 2015, and Oct. 13, 2021.
Estimated Amount: Varies.
Proof of Purchase: Settlement Administrator may ask for additional proof supporting your claim.
1. Itemized receipts that show payment(s) for the subject drugs; or
2. An EOB (explanation of benefits) from your insurer that shows you paid for the subject drugs; or
3. Records from your pharmacy showing that you paid for the subject drugs; or
4. Copies of records showing prescriptions written for the subject drugs.
Case Name & Number: Belton, et al. v. GE Capital Consumer Lending Inc., Adv. Pro. No. 1408223 in the U.S. District Court for the Southern District of New York

File a Claim

(Click here to file a claim)

How To File a Claim

Head over to the Evotaz, Atripla HIV Drugs Antitrust Claim Form.
Read over the claim form to see if you are eligible.
Complete the claim form with your info.
Submit your claim form to receive your potential award by June 27, 2022!

Bottom Line

If you are eligible, file a claim by the deadline to receive your potential award! Don’t forget to take a look at our full list of Class Action Lawsuit Settlements! Be sure to give our list of No-Proof Class Action lawsuit to see other settlements you may qualify for.